Polsinelli invites you to join us for the next event in our complimentary 2014 webinar series: Know the Road Ahead ... Insights for Your Business. Partner with our business-minded Litigation team as we discuss:
FDA Proposed Rules to Hatch Liability for Generic Drug Makers, Waxing Mensing's Preemption Defense
Wednesday, February 26, 2014
On our Agenda:
In November 2013, the FDA announced a proposed rule that would put generic drug manufacturers on the same "products liability" footing as branded manufacturers. By requiring generic manufacturers to update their labels to take into account new safety data, the FDA's proposed changes would effectively overrule Pliva v. Mensing, which barred most state law products liability suits against generic drug manufacturers on federal preemption grounds. The proposed changes will create significant duties and liabilities for generic drug manufacturers and will impact the entire healthcare system.
- Cary Hall, Shareholder | Practice Chair, Products Liability
- John Barwell, Associate, Products Liability
To view the full invitation, click here.